NCT02656472View on ClinicalTrials.gov

A Pilot Study Comparing Anti-Inflammatory Effects Of TXA Versus EACA In Pediatric Congenital Heart Surgery

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions

Pediatric Cardiac SurgeryComplication of Extracorporeal Circulation

Interventions

DRUG

Tranexamic acid

TXA Loading dose: 31 mg/kg diluted to 2 ml/kg Normal saline (NS) -in syringe

DRUG

Epsilon Aminocaproic Acid

Aminocaproic acid Loading dose: 75 mg/kg diluted to 2 ml/kg NS

Trial Locations (1)

60453

Advocate Childrens Hospital, Oak Lawn

All Listed Sponsors

lead

Wake Forest University Health Sciences

OTHER

NCT02656472 - A Pilot Study Comparing Anti-Inflammatory Effects Of TXA Versus EACA In Pediatric Congenital Heart Surgery | Biotech Hunter | Biotech Hunter